by The global transfection reagents and equipment market consists of reagents and equipment that are used to introduce nucleic acids (genetic materials such as DNA and RNA molecules) into cells. Transfection reagents play a vital role in many procedures such as gene expression, protein production, validation of gene function and RNA interference. Liposomes, calcium phosphate, DEAE-dextran and dendrimers are some commonly used transfection reagents. The equipment category includes instruments such as cuvettes, electroporators and gene guns which help in the delivery of genetic materials inside cells. Transfection finds widespread application in molecular and cell biology research, protein production and therapeutic delivery.
The global transfection reagents and equipment market is estimated to be valued at US$ 1342.78 billion in 2023 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The rising demand for novel drug discovery is expected to drive the growth of the transfection reagents and equipment market. Transfection plays a vital role in identification as well as validation of new drug targets through large scale functional genomics studies. Moreover, with growing burden of diseases like cancer, neurological disorders and genetic illnesses, pharmaceutical companies are actively involved in development of new biologics, vaccines and gene therapies which require efficient transfection techniques. This is further anticipated to propel the market growth over the forecast period. Additionally, advanced technologies like CRISPR/Cas9 genome editing have opened up new possibilities in biomedical research and require transfection reagents and equipment for their applications, thereby fuelling the market growth. However, low transfection efficiency of certain reagents, high costs associated with equipment and biosafety issues related to gene delivery pose a challenge to market growth.
Segment Analysis
The transfection reagents and equipment market can be segmented into kits, reagents, instruments, by application into gene expression, protein production and others. The reagents sub-segment dominates the market currently as it is an indispensable part of transfection process. The demand for reagents is more consistent throughout the year as opposed to instruments which see demand in a few quarters. Further, reagents can be stored for longer duration without deterioration in quality making them more reliable option.
PEST Analysis
Political: The market is governed by stringent regulations for genetically modified organisms. Changes in regulatory policies across regions impacts market dynamics.
Economic: Rising healthcare spending coupled with economic growth in emerging nations aids market expansion. However, costs of transfection could limit uptake.
Social: Growing population and focus on research for diseases pushes market growth. However, ethical concerns regarding genetic modification acts as a challenge.
Technological: Advancements in transfection technologies and protocols improve efficiency fostering market growth. CRISPR and other gene editing tools open new opportunities.
Key Takeaways
The Global Transfection Reagents And Equipment Market Size is expected to witness high growth over the forecast period. The global transfection reagents and equipment market is estimated to be valued at US$ 1342.78 billion in 2023 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024 to 2031.
North America currently dominates the market led by the large biotech industry and concentration of key market players in the region. The region is also expected to grow at a high CAGR through 2031 supported by strong government funding on life sciences R&D.
Key players operating in the transfection reagents and equipment market are Nestle Waters, PepsiCo, Inc., The Coca-Cola Company, Groupe Danone, Suntory Beverage & Food Ltd, Mountain Valley Spring Company, LLC, and CG Roxane, LLC.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
